CMA vs IMNM
CMA (CMA) versus Immunome Inc (IMNM) — a side-by-side from cached financials, not a winner call.
CMA (CMA) common stock.
Immunome Inc (IMNM) is a biotechnology company listed on US.
CMA does not have a complete income-statement cache yet.
Latest reported IMNM revenue for 2026-06-30 was $0. Net income was -$127.0M. IMNM currently screens at market cap $2.47B.
IMNM currently screens at market cap $2.47B.
Not investment advice. Open the CMA and IMNM stock pages for the full models.
Not investment advice.